Advocate for the protection of the Medicare GPO Safe Harbor as it relates to provider transparency provisions.
Work on medical supply chain issues impacting drug shortages for inpatient facilities. Advocate for SNS product rotation, buffer stock, private sector collaboration and updated FDA drug shortage warnings. This includes work on S. 2510, the RAPID Reserve Act.
Work on reauthorization of the Pandemic All Hazards Preparedness Act, including H.Res. 1061 the "Consolidated Appropriations Act of 2024,"
Duration: October 28, 2013
to
present
General Issues: Medicare/Medicaid , Health Issues , Disaster Planning/Emergencies , Taxation/Internal Revenue Code , Pharmacy , Budget/Appropriations , Labor Issues/Antitrust/Workplace
Spending: about $1,514,750 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2013: U.S. Senate, House of Representatives, Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS), Commerce - Dept of (DOC), State - Dept of (DOS)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Diane Major Mrs. Health Policy Analyst for Sen. Repub. Policy Com.
Health Leg. Assistant for Sen. Craig Thomas
Professional Staff Member for Com on Gov't Operations
Health Leg. Assistant for Rep. Craig Thomas
Diane Major Health Policy Analyst for Senate Republican Policy Committee
Health Policy Analyst for Sen. Repub. Policy Com.
Health Leg. Assistant for Sen. Craig Thomas
Professional Staff Member for Com. on Gov't Ops
Health Leg. Assistant for Rep. Craig Thomas
Brenda Reese Conference Coordinator for House Republican Conference
Conference Coordinator for House Repub. Conf.
Assistant to Assistant Sec. of Gov't Affairs DOT
Scheduler for Rep. Mickey Edwards
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, The D Major Group lobbied for Health Care Supply Chain Association , earning $40,000. The report was filed on April 18.
Original Filing: 301554004.xml
Lobbying Issues
Advocate for the protection of the Medicare GPO Safe Harbor as it relates to provider transparency provisions.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Work on medical supply chain issues impacting drug shortages for inpatient facilities. Advocate for SNS product rotation, buffer stock, private sector collaboration and updated FDA drug shortage warnings. This includes work on S. 2510, the RAPID Reserve Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Work on reauthorization of the Pandemic All Hazards Preparedness Act, including H.Res. 1061 the "Consolidated Appropriations Act of 2024,"
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies
4th Quarter, 2023
In Q4, The D Major Group lobbied for Health Care Supply Chain Association , earning $40,000. The report was filed on Jan. 12.
Original Filing: 301524002.xml
Lobbying Issues
Advocate for the protection of the Medicare GPO Safe Harbor as it relates to provider transparency provisions.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Work on medical supply chain issues impacting drug shortages for inpatient facilities. Advocate for SNS product rotation, buffer stock, private sector collaboration and updated FDA drug shortage warnings. This includes work on S. 2510, the RAPID Reserve Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Work on reauthorization of the Pandemic All Hazards Preparedness Act.
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies
3rd Quarter, 2023
In Q3, The D Major Group lobbied for Health Care Supply Chain Association , earning $40,000. The report was filed on Oct. 19, 2023.
Original Filing: 301509450.xml
Lobbying Issues
Advocate for the protection of the Medicare GPO Safe Harbor as it relates to provider transparency provisions.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Work on medical supply chain issues impacting drug shortages for inpatient facilities. Advocate for SNS product rotation, private sector collaboration and updated FDA drug shortage warnings.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor legislative and regulatory proposals concerning the expiration of the Public Health Emergency. Work on reauthorization of the Pandemic All Hazards Preparedness Act.
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies
2nd Quarter, 2023
In Q2, The D Major Group lobbied for Health Care Supply Chain Association , earning $40,000. The report was filed on July 16, 2023.
Original Filing: 301477258.xml
Lobbying Issues
Advocate for the protection of the Medicare GPO Safe Harbor as it relates to provider transparency provisions.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Work on medical supply chain issues impacting drug shortages for inpatient facilities. Advocate for SNS product rotation, private sector collaboration and updated FDA drug shortage warnings.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor legislative and regulatory proposals concerning the expiration of the Public Health Emergency. Work on reauthorization of the Pandemic All Hazards Preparedness Act.
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies
1st Quarter, 2023
In Q1, The D Major Group lobbied for Health Care Supply Chain Association , earning $40,000. The report was filed on April 7, 2023.
Original Filing: 301449770.xml
Lobbying Issues
Advocate for the protection of the Medicare GPO Safe Harbor.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Work on medical supply chain issues impacting drug shortages for inpatient facilities.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor legislative and regulatory proposals concerning the expiration of the Public Health Emergency. Work on reauthorization of the Pandemic All Hazards Preparedness Act.
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies
4th Quarter, 2022
In Q4, The D Major Group lobbied for Health Care Supply Chain Association , earning $40,000. The report was filed on Jan. 15, 2023.
Original Filing: 301427816.xml
Lobbying Issues
Advocate for the protection of the Medicare GPO safe harbor and attributed health care cost savings.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Work on Strategic National Stockpile and other emergency preparedness items included in HR 2617, the "Consolidated Appropriations Act of FY23." Monitor impact of drug pricing reforms as passed in HR 5376, the "Inflation Reduction Act."
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor H.R. 3463 and S. 1695, the Medical Supplies for Pandemics Act. Also work on supply chain issues related to S. 1260, the US Innovation and Competition Act, as well as SNS and ASPR issues contained in S. 3799, the PREVENT Pandemics Act.
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies
3rd Quarter, 2022
In Q3, The D Major Group lobbied for Health Care Supply Chain Association , earning $40,000. The report was filed on Oct. 17, 2022.
Original Filing: 301405816.xml
Lobbying Issues
Advocate for the protection of the Medicare GPO safe harbor and attributed health care cost savings.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Work on drug shortage issues, including provisions related to the FDA User Fee Reauthorization measure as passed in HR 6833, the "Continuing Appropriations & Ukraine Supplemental Appropriations Act." Monitor drug pricing legislation included in HR 5376, the "Inflation Reduction Act."
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor H.R. 3463 and S. 1695, the Medical Supplies for Pandemics Act. Also work on supply chain issues related to S. 1260, the US Innovation and Competition Act, as well as SNS and ASPR issues contained in S. 3799, the PREVENT Pandemics Act.
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies
2nd Quarter, 2022
In Q2, The D Major Group lobbied for Health Care Supply Chain Association , earning $40,000. The report was filed on July 10, 2022.
Original Filing: 301378532.xml
Lobbying Issues
Advocate for the protection of the Medicare GPO safe harbor and attributed health care cost savings.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Work on drug shortage issues. Also monitor HR 7667, the Food and Drug Amendments Act of 2022; as well as S. 4348, the Food and Drug Administration Safety and Landmark Advancements Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor H.R. 3463 and S. 1695, the Medical Supplies for Pandemics Act. Also work on supply chain issues related to S. 1260, the US Innovation and Competition Act, as well as SNS and ASPR issues contained in S. 3799, the PREVENT Pandemics Act.
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies
1st Quarter, 2022
In Q1, The D Major Group lobbied for Health Care Supply Chain Association , earning $40,000. The report was filed on April 19, 2022.
Original Filing: 301363352.xml
Lobbying Issues
Advocate for the protection of the Medicare GPO safe harbor and attributed health care cost savings.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Work on visibility issues concerning regional and national medical supply shortage concerns.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor H.R. 3463 and S. 1695, the Medical Supplies for Pandemics Act. Also work on supply chain issues related to S. 1260, the US Innovation and Competition Act, as well as SNS and ASPR issues contained in S. 3799, the PREVENT Pandemics Act.
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies
4th Quarter, 2021
In Q4, The D Major Group lobbied for Health Care Supply Chain Association , earning $40,000. The report was filed on Jan. 17, 2022.
Original Filing: 301323884.xml
Lobbying Issues
Advocate for the protection of the Medicare GPO safe harbor and attributed health care cost savings.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Work on visibility issues concerning regional and national medical supply shortage concerns.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor H.R. 3463 and S. 1695, the Medical Supplies for Pandemics Act. Also work on supply chain issues related to H.R. 3684, the Infrastructure Investment and Jobs Act, and other domestic manufacturing and emergency preparedness matters concerning SNS and ASPR. As well as H.R. 5376, the Build Back Better Act.
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies
3rd Quarter, 2021
In Q3, The D Major Group lobbied for Health Care Supply Chain Association , earning $40,000. The report was filed on Oct. 16, 2021.
Original Filing: 301300609.xml
Lobbying Issues
Advocate for the protection of the Medicare GPO safe harbor and attributed health care cost savings.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Work on visibility issues concerning regional and national medical supply shortage concerns.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor H.R. 3463 and S. 1695, the Medical Supplies for Pandemics Act. Also work on supply chain issues related to H.R. 3684, the Infrastructure Investment and Jobs Act, and other domestic manufacturing and emergency preparedness matters concerning SNS and ASPR.
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies
2nd Quarter, 2021
In Q2, The D Major Group lobbied for Health Care Supply Chain Association , earning $40,000. The report was filed on July 18, 2021.
Original Filing: 301279412.xml
Lobbying Issues
Advocate for the protection of the Medicare GPO safe harbor and attributed health care cost savings.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Work on visibility issues concerning regional and national medical supply shortage concerns.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor supply chain issues related to domestic manufacturing and emergency preparedness, including SNS and ASPR.
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies
1st Quarter, 2021
In Q1, The D Major Group lobbied for Health Care Supply Chain Association , earning $40,000. The report was filed on April 19, 2021.
Original Filing: 301257412.xml
Lobbying Issues
Advocate for the protection of the Medicare GPO safe harbor and attributed health care cost savings.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Work on medical supply visibility issues concerning regional and national shortage concerns.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor domestic manufacturing and supply chain issues including provisions related to HR 1319, the American Rescue Plan of 2021.
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies
4th Quarter, 2020
In Q4, The D Major Group lobbied for Health Care Supply Chain Association , earning $40,000. The report was filed on Jan. 18, 2021.
Original Filing: 301233873.xml
Lobbying Issues
Advocate for the protection of the Medicare GPO safe harbor and attributed health savings. Also, raised industry concerns related to bona fide services as proposed under S. 2543, the Prescription Drug Pricing Reduction Act (PDPRA) of 2019.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Work on medical supply chain issues related to HR 133, the Consolidated Appropriations Act. Advocate for market-based reforms concerning inpatient drug shortages including, S.2723 the Mitigating Emergency Drug Shortages Act; HR 6080, the Preventing Drug Shortages Act; and S. 3343, the Medical Supply Chain Security Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Work on public health funding concerning HR 133, the Consolidated Appropriations Act. This includes matters related to stockpiling and other readiness issues during an emergency.
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies
3rd Quarter, 2020
In Q3, The D Major Group lobbied for Health Care Supply Chain Association , earning $40,000. The report was filed on Oct. 14, 2020.
Original Filing: 301209985.xml
Lobbying Issues
Advocate for the protection of the Medicare GPO safe harbor and attributed health savings. Also, raised industry concerns related S. 1895, the Lower Health Care Costs Act of 2019; and revised definition of bona fide services as proposed under S. 2543, the Prescription Drug Pricing Reduction Act (PDPRA) of 2019.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Advocate for market-based reforms concerning inpatient drug shortages including, S.2723 the Mitigating Emergency Drug Shortages Act; HR 6080, the Preventing Drug Shortages Act; and S. 3343, the Medical Supply Chain Security Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Work on supply chain mitigation issues related to H.R.6074, the Coronavirus Preparedness and Response Supplemental Appropriations Act; H.R.6201, the Families First Coronavirus Response Act; and S. 3548 the Coronavirus Aid, Relief, and Economic Security (CARES) Act.
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies
2nd Quarter, 2020
In Q2, The D Major Group lobbied for Health Care Supply Chain Association , earning $40,000. The report was filed on July 18, 2020.
Original Filing: 301192948.xml
Lobbying Issues
Advocate for the protection of the Medicare GPO safe harbor and attributed health savings. Also, raised industry concerns related S. 1895, the Lower Health Care Costs Act of 2019; and revised definition of bona fide services as proposed under S. 2543, the Prescription Drug Pricing Reduction Act (PDPRA) of 2019.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Advocate for market-based reforms concerning inpatient drug shortages including, S.2723 the Mitigating Emergency Drug Shortages Act; HR 6080, the Preventing Drug Shortages Act; and S. 3343, the Medical Supply Chain Security Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Work on supply chain mitigation issues related to H.R.6074, the Coronavirus Preparedness and Response Supplemental Appropriations Act; H.R.6201, the Families First Coronavirus Response Act; and S. 3548 the Coronavirus Aid, Relief, and Economic Security Act.
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies
1st Quarter, 2020
In Q1, The D Major Group lobbied for Health Care Supply Chain Association , earning $40,000. The report was filed on April 18, 2020.
Original Filing: 301171661.xml
Lobbying Issues
Advocate for the protection of the Medicare GPO safe harbor and attributed health savings. Also, raised industry concerns related S. 1895, the Lower Health Care Costs Act of 2019; and revised definition of bona fide services as proposed under S. 2543, the Prescription Drug Pricing Reduction Act (PDPRA) of 2019.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Advocate for market-based reforms concerning inpatient drug shortages including, S.2723 the Mitigating Emergency Drug Shortages Act; HR 6080, the Preventing Drug Shortages Act; and S. 3343, the Medical Supply Chain Security Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Worked on supply chain mitigation issues related to H.R.6074, the Coronavirus Preparedness and Response Supplemental Appropriations Act; H.R.6201, the Families First Coronavirus Response Act; and S. 3548 the Coronavirus Aid, Relief, and Economic Security Act.
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies
4th Quarter, 2019
In Q4, The D Major Group lobbied for Health Care Supply Chain Association , earning $40,000. The report was filed on Jan. 12, 2020.
Original Filing: 301104553.xml
Lobbying Issues
Advocate for the protection of the Medicare GPO safe harbor and attributed health savings. Also, raised industry concerns related S. 1895, the Lower Health Care Costs Act of 2019; and revised definition of bona fide services as proposed under S. 2543, the Prescription Drug Pricing Reduction Act (PDPRA) of 2019.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Advocate for market-based reforms concerning inpatient drug shortages including, S.2723 the Mitigating Emergency Drug Shortages Act.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2019
In Q3, The D Major Group lobbied for Health Care Supply Chain Association , earning $40,000. The report was filed on Oct. 16, 2019.
Original Filing: 301067203.xml
Lobbying Issues
Advocate for the protection of the Medicare GPO safe harbor and attributed health savings. Also, raised industry concerns related to S. 102, the Prescription Drug Pricing Reduction Act (PDPRA) of 2019; as well as S.1895, the Lower Health Care Costs Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor drug shortage proposals affecting the pharmaceutical supply chain.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2019
In Q2, The D Major Group lobbied for Health Care Supply Chain Association , earning $40,000. The report was filed on July 14, 2019.
Original Filing: 301045445.xml
Lobbying Issues
Advocate for the protection of the Medicare GPO safe harbor and attributed health savings.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor drug shortage and pricing proposals, including S. 1895, The Lower Health Care Costs Act, and promote GPO industry best practices.
Agencies Lobbied
U.S. Senate
1st Quarter, 2019
In Q1, The D Major Group lobbied for Health Care Supply Chain Association , earning $40,000. The report was filed on April 14, 2019.
Original Filing: 301025009.xml
Lobbying Issues
Advocate for the protection of the Medicare GPO safe harbor and attributed health savings.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Educate policymakers on GPO emergency response systems, inpatient drug shortage issues and improved market competition affected by FDA approval processes.
Agencies Lobbied
U.S. Senate
4th Quarter, 2018
In Q4, The D Major Group lobbied for Health Care Supply Chain Association , earning $40,000. The report was filed on Jan. 14, 2019.
Original Filing: 301004360.xml
Lobbying Issues
Monitor protection of the Medicare safe harbor for GPOs and its contribution to corresponding health care savings.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Engage with policymakers on issues related to supply chain management, including drug shortages administered in inpatient settings, as well as in response to emergency preparedness situations. Also, advocate for cybersecurity standards for devices and related informatics.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2018
In Q3, The D Major Group lobbied for Health Care Supply Chain Association , earning $40,000. The report was filed on Oct. 17, 2018.
Original Filing: 300987806.xml
Lobbying Issues
Monitor protection of the Medicare safe harbor for GPOs and its contribution to corresponding health care savings.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Engage with policymakers on issues related to supply chain management, including drug shortages administered in inpatient settings, as well as in response to emergency preparedness situations. Also, advocate for cybersecurity standards for devices and related informatics.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor technical corrections to HR 1, the "Tax Cuts & Jobs Act."
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2018
In Q2, The D Major Group lobbied for Health Care Supply Chain Association , earning $40,000. The report was filed on July 17, 2018.
Original Filing: 300967081.xml
Lobbying Issues
Monitor protection of the Medicare safe harbor for GPOs and its contribution to corresponding health care savings.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Engage with policymakers on issues related to supply chain management, including access to products in emergency preparedness situations, increased market competition for FDA approved products, and cybersecurity standards for devices and related informatics.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor technical corrections to HR 1, the "Tax Cuts & Jobs Act."
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2018
In Q1, The D Major Group lobbied for Health Care Supply Chain Association , earning $35,000. The report was filed on April 14, 2018.
Original Filing: 300944748.xml
Lobbying Issues
Monitor protection of the Medicare safe harbor for GPOs and its contribution to corresponding health care savings.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Engage with policymakers on issues related to supply chain management, including access to products in emergency preparedness situations, increased market competition for FDA approved products, and cybersecurity standards for devices and related informatics.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor technical corrections to HR 1, the "Tax Cuts & Jobs Act."
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2017
In Q4, The D Major Group lobbied for Health Care Supply Chain Association , earning $35,000. The report was filed on Jan. 12, 2018.
Original Filing: 300923504.xml
Lobbying Issues
Monitor protection of the Medicare safe harbor for GPOs and its contribution to corresponding health care savings.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Engage with policymakers on issues related to supply chain management, including access to products in emergency preparedness situations, streamlined FDA procedures for generic medicine applications, and cybersecurity.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Monitor non-profit organization provisions included in HR 1, the "Tax Cuts & Jobs Act."
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2017
In Q3, The D Major Group lobbied for Health Care Supply Chain Association , earning $36,750. The report was filed on Oct. 20, 2017.
Original Filing: 300916848.xml
Lobbying Issues
Monitor protection of the Medicare safe harbor for GPOs and its contribution to corresponding health care savings.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Engage with policymakers on issues related to increased competition for generic medicines. This includes HR 2430, the FDA Reauthorization Act of 2017; and S. 934, the Food and Drug Administration Reauthorization Act.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2017
In Q2, The D Major Group lobbied for Health Care Supply Chain Association , earning $36,750. The report was filed on July 16, 2017.
Original Filing: 300885267.xml
Lobbying Issues
Monitor protection of the Medicare safe harbor for GPOs and its contribution to corresponding health care savings.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Engage with policymakers on issues related to increased competition for generic medicines. This includes HR 2430, the FDA Reauthorization Act of 2017; and S. 934, the Food and Drug Administration Reauthorization Act.
Agencies Lobbied
U.S. Senate
1st Quarter, 2017
In Q1, The D Major Group lobbied for Health Care Supply Chain Association , earning $36,750. The report was filed on April 14, 2017.
Original Filing: 300865819.xml
Lobbying Issues
Monitor impact of health policy changes on health care supply chain. This includes H.R. 1628, the American Health Care Act of 2017.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Engage with policymakers on issues related to increased competition for generic medicines. This includes HR 749 and S. 297, the Lower Drug Costs through Competition Act.
Agencies Lobbied
U.S. Senate
4th Quarter, 2016
In Q4, The D Major Group lobbied for Health Care Supply Chain Association , earning $32,250. The report was filed on Jan. 16, 2017.
Original Filing: 300846936.xml
Lobbying Issues
Protection of Group Purchasing Organization Safe Harbor provision.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues affecting supply chain management including health information technology matters related to S. 2511, The Improving Health IT Act. Also, advocate for improved FDA review processes related to H.R. 4784 & S. 2615, The Increasing Competition in Pharmaceuticals Act. Monitor H.R. 34, the "21st Century Cures Act."
Agencies Lobbied
U.S. Senate
3rd Quarter, 2016
In Q3, The D Major Group lobbied for Health Care Supply Chain Association , earning $32,250. The report was filed on Oct. 19, 2016.
Original Filing: 300831822.xml
Lobbying Issues
Protection of Group Purchasing Organization Safe Harbor provision.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues affecting supply chain management including health information technology matters related to S. 2511, The Improving Health IT Act. Also, advocate for improved FDA review processes including matters related to H.R. 4784 & S. 2615, The Increasing Competition in Pharmaceuticals Act.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2016
In Q2, The D Major Group lobbied for Health Care Supply Chain Association , earning $30,000. The report was filed on July 16, 2016.
Original Filing: 300810927.xml
Lobbying Issues
Protection of Group Purchasing Organization Safe Harbor provision.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues affecting supply chain management including health information technology matters related to S. 2511, The Improving Health IT Act. Also, advocate for improved FDA review processes including matters related to S. 2615, The Increasing Competition in Pharmaceuticals Act.
Agencies Lobbied
U.S. Senate
1st Quarter, 2016
In Q1, The D Major Group lobbied for Health Care Supply Chain Association , earning $30,000. The report was filed on April 19, 2016.
Original Filing: 300794299.xml
Lobbying Issues
Protection of Group Purchasing Organization Safe Harbor provision.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues affecting supply chain management including health information technology matters related to S. 2511, The Improving Health IT Act. Also, advocate for improved FDA review processes including matters related to S. 2615, The Increasing Competition in Pharmaceuticals Act.
Agencies Lobbied
U.S. Senate
4th Quarter, 2015
In Q4, The D Major Group lobbied for Health Care Supply Chain Association , earning $30,000. The report was filed on Jan. 14, 2016.
Original Filing: 300772300.xml
Lobbying Issues
Protection of Group Purchasing Organization Safe Harbor provision.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Supply chain industry issues concerning health information technology, biosimilar labeling and FDA review of generic medicine applications.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2015
In Q3, The D Major Group lobbied for Health Care Supply Chain Association , earning $30,000. The report was filed on Oct. 15, 2015.
Original Filing: 300753913.xml
Lobbying Issues
Protection of Group Purchasing Organization Safe Harbor provision.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Advocate for supply chain industry issues concerning health information technology, biosimilar labeling and FDA review of generic medicine applications.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2015
In Q2, The D Major Group lobbied for Health Care Supply Chain Association , earning $30,000. The report was filed on July 13, 2015.
Original Filing: 300733287.xml
Lobbying Issues
Protection of Group Purchasing Organization Safe Harbor provision. Monitor physician and hospital payment matters, including H.R. 2, the Medicare Access & CHIP Reauthorization Act of 2015.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues concerning H.R. 6, the 21st Century Cures Act, including health information technology issues affecting supply chain managers.
Agencies Lobbied
U.S. Senate
1st Quarter, 2015
In Q1, The D Major Group lobbied for Health Care Supply Chain Association , earning $30,000. The report was filed on April 17, 2015.
Original Filing: 300717897.xml
Lobbying Issues
Protection of Group Purchasing Organization Safe Harbor provision. Monitor physician and hospital payment matters, including H.R. 2, the Medicare Access & CHIP Reauthorization Act of 2015.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health information technology issues affecting supply chain management.
Agencies Lobbied
U.S. Senate
4th Quarter, 2014
In Q4, The D Major Group lobbied for Health Care Supply Chain Association , earning $10,000. The report was filed on Jan. 17, 2015.
Original Filing: 300699370.xml
Lobbying Issues
Issues concerning the Medicare program, specifically protection of the safe harbor provision.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues concerning supply chain readiness as related to S. 2942, the "Infectious Disease Hospital Hubs Act."
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies
Lobbying Issues
Issues related to the implementation of the Drug Quality and Supply Act.
Agencies Lobbied
U.S. Senate
4th Quarter, 2014
The D Major Group amended a lobbying report for representation of Health Care Supply Chain Association in Q42014 on Jan. 17, 2015.
Original Filing: 300699383.xml
Lobbying Issues
Issues concerning the Medicare program, specifically protection of the safe harbor provision.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues concerning supply chain readiness as related to S. 2942, the "Infectious Disease Hospital Hubs Act."
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies
Lobbying Issues
Issues related to the implementation of the Drug Quality and Supply Act.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2014
In Q3, The D Major Group lobbied for Health Care Supply Chain Association , earning $30,000. The report was filed on Oct. 10, 2014.
Original Filing: 300675310.xml
Lobbying Issues
Issues concerning the Medicare program, including protection of the safe harbor provision.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation issues concerning the Drug Quality and Supply Act.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2014
In Q2, The D Major Group lobbied for Health Care Supply Chain Association , earning $30,000. The report was filed on July 18, 2014.
Original Filing: 300663177.xml
Lobbying Issues
Policy issues associated with Medicare payment
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Implementation issues associated with The Drug Quality and Security Act
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2014
In Q1, The D Major Group lobbied for Health Care Supply Chain Association , earning $30,000. The report was filed on April 17, 2014.
Original Filing: 300638368.xml
Lobbying Issues
H.R. 4302, The Protecting Access to Medicare Act of 2014
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. The Consolidated Appropriations Act of 2014
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 3204, The Drug Quality and Security Act
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2013
In Q4, The D Major Group lobbied for Health Care Supply Chain Association , earning $30,000. The report was filed on Jan. 18, 2014.
Original Filing: 300619926.xml
Lobbying Issues
H.R. 2810, The Medicare Patient Access and Quality Improvement Act of 2013
The SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013 (Senate Finance)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.J. Res. 59, The Bipartisan Budget Act of 2013
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 3204, The Drug Quality and Security Act
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2013
The D Major Group filed a lobbying registration on Dec. 1, 2013 to represent Health Care Supply Chain Association, effective Oct. 28, 2013.
Original Filing: 300610239.xml
Issue(s) they said they’d lobby about: Issues related to supply chain management of health care goods and services. .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...